Press-release for stocks published on previous years

Prices are updated after-hours

approved published : Previous years

save search

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K

Manufacturing

| Email alert Add to watchlist
ALPMF | News | $9.75 43.47% 200

Health Technology

| Email alert Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M

Health Technology

| Email alert Add to watchlist
granted approval cancer treatment for

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DAWN S | $16.65 8.26% 7.63% 6.6M

Professional, Scientific, and T...

| Email alert Add to watchlist
day fda approval tumor for

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| 0.0% | O: 4.32% H: 0.0% C: 0.0%
lutathera fda first approved tumors for novartis therapy

FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M

Health Technology

| 0.0% | O: 0.3% H: 0.0% C: 0.0%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.53% | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M

Health Technology

| 0.0% | O: 0.47% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 0.0% | O: 1.7% H: 0.0% C: 0.0%
fda bladder cancer treatment

Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
AMTX | $3.89 7.31% 6.81% 1.2M

Process Industries

| -5.47% | O: -1.17% H: 0.0% C: 0.0%
approval review million for funding

BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K

Health Technology

| -0.17% | O: 4.09% H: 0.0% C: 0.0%
lung approval cancer cell treatment for

Todays' Top-5
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Published: 2024-04-23 (Crawled : 07:00) - biospace.com/
IBRX | $5.48 10.93% 9.85% 31M

Manufacturing

| 0.0% | O: 17.35% H: 0.0% C: 0.0%
il-15 anktiva fda agonist approval bladder cancer for

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.82% | O: 0.29% H: 0.0% C: 0.0%
LEGN | News | $47.42 0.77% 0.76% 1.8M

Health Technology

| 1.88% | O: 0.39% H: 1.73% C: 1.49%
carvykti approved treatment for

Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
LTRN | News | $5.8 1.4% 1.38% 130K

Health Technology

| 7.12% | O: 6.74% H: 5.26% C: 0.35%
lung pharma japan approval cancer cell for trial

CARFAX Car Listings Approved for GM's IMR Turnkey Program
Published: 2024-04-22 (Crawled : 17:00) - prnewswire.com
SPGI | News | $413.26 -0.88% 0.0% 2.2M

Commercial Services

| 1.06% | O: 0.59% H: 0.7% C: 0.47%
approved for program

European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M

Health Technology

| 1.0% | O: 0.0% H: 1.92% C: 1.0%
emblaveo treatment for infections

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.82% | O: 0.29% H: 0.0% C: 0.0%
fda clearance system for ice

Chesapeake Utilities Corporation Gains Approval to Establish Energy Efficiency Programs in Delaware
Published: 2024-04-22 (Crawled : 13:00) - prnewswire.com
CPK | News | $105.67 -0.05% 0.0% 73K

Utilities

| 0.87% | O: -0.01% H: 0.94% C: 0.88%
energy approval corporation

Science Based Targets initiative Approves Otis Targets for Reducing Greenhouse Gas Emissions
Published: 2024-04-22 (Crawled : 11:00) - prnewswire.com
OTIS | News | $97.47 1.23% 0.0% 2.1M

Producer Manufacturing

| 0.67% | O: -0.22% H: 1.51% C: 0.9%
initiative gas for

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
SBFM | $1.235 -14.24% -22.03% 5.9M

Professional, Scientific, and T...

| -78.82% | O: -65.59% H: 4.7% C: -24.79%
pharma biosimilar health approval for canada

Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M

Health Technology

| 1.25% | O: 0.22% H: 0.37% C: 0.1%
health treatment for canada advanced keytruda

ContextLogic Announces Stockholder Approval of Transaction with Qoo10
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
WISH | $5.99 2.22% 2.17% 690K